Recent studies demonstrated that bi-specific Trop2/PD-L1 CAR-T cells can meaningfully decline gastric cancer growth through intratumoral injection, with a more prominent suppression effect than Trop2-specific CAR-T cells. The gene discussed is CD274; the disease is gastric cancer.